Skip to main content
Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
0.6840
-1.2460 (-64.56%)
At close: Nov 11, 2026, 4:00 PM EST
0.6834
-0.0006 (-0.09%)
After-hours: Nov 11, 2026, 7:59 PM EST

Basel Medical Group Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
11133---
Market Cap Growth
-95.91%-67.46%----
Enterprise Value
81229---
Last Close Price
1.936.9521.36---

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
0.060.653.75---
PB Ratio
0.793.107.83---
P/TBV Ratio
0.262.787.84---

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
0.480.733.30---

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
2.122.121.200.761.312.74
Debt / EBITDA Ratio
3.103.10-2.102.823.34
Debt / FCF Ratio
---2.282.783.76
Net Debt / Equity Ratio
2.002.00-0.600.491.082.29
Net Debt / EBITDA Ratio
-20.67-20.671.621.652.903.42
Net Debt / FCF Ratio
-10.29-10.290.721.472.273.14
Asset Turnover
1.181.180.650.630.61-
Inventory Turnover
36.5936.5931.9070.6667.92-
Quick Ratio
1.101.101.220.550.630.63
Current Ratio
1.231.231.312.262.282.18
Return on Equity (ROE)
-28.66%-28.66%-163.64%31.77%38.79%-
Return on Assets (ROA)
-2.71%-2.71%-7.65%8.66%7.77%-
Return on Invested Capital (ROIC)
-5.80%-10.02%-32.00%16.73%14.21%16.72%
Return on Capital Employed (ROCE)
-10.00%-10.00%-25.10%24.00%22.50%25.50%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-88.12%-5.31%-24.98%---
FCF Yield
-68.41%-6.28%-10.81%---
Buyback Yield / Dilution
-1.06%-1.06%-15.60%---
SEC Filings: 10-K · 10-Q